Individualized immunosuppressive and antiretroviral drug therapy by liquid chromatography-mass spectrometry assisted drug monitoring

被引:0
|
作者
Kaever, V [1 ]
Koal, T [1 ]
机构
[1] Hannover Med Sch, Inst Pharmakol, D-30625 Hannover, Germany
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:709 / 710
页数:2
相关论文
共 50 条
  • [31] Therapeutic drug monitoring of immunosuppressant drugs by liquid chromatography-tandem mass spectrometry
    Taylor, P. J.
    Franklin, M. E.
    Tai, C. -H.
    Pillans, P. I.
    CLINICA CHIMICA ACTA, 2010, 411 (11-12) : 904 - 904
  • [32] Derivatization for liquid chromatography-mass spectrometry
    Qi, Bao-Ling
    Liu, Ping
    Wang, Qiu-Yi
    Cai, Wen-Jing
    Yuan, Bi-Feng
    Feng, Yu-Qi
    TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2014, 59 : 121 - 132
  • [33] ONLINE DIRECT LIQUID INTRODUCTION INTERFACE FOR MICRO-LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY - APPLICATION TO DRUG ANALYSIS
    ECKERS, C
    SKRABALAK, DS
    HENION, J
    CLINICAL CHEMISTRY, 1982, 28 (09) : 1882 - 1886
  • [34] CHARACTERIZATION OF STEROIDAL DRUG METABOLITES BY COMBINED GAS CHROMATOGRAPHY-MASS SPECTROMETRY
    BROOKS, CJW
    THAWLEY, AR
    ROCHER, P
    MIDDLEDITCH, BS
    ANTHONY, GM
    STILLWELL, WG
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1971, 9 (01) : 35 - +
  • [36] Hyphenated techniques in anticancer drug monitoring. I. Capillary gas chromatography-mass spectrometry
    Guetens, G
    De Boeck, G
    Wood, M
    Maes, RAA
    Eggermont, AAM
    Highley, MS
    van Oosterom, AT
    de Bruijn, EA
    Tjaden, UR
    JOURNAL OF CHROMATOGRAPHY A, 2002, 976 (1-2) : 229 - 238
  • [37] Determination of anti-cancer drug actinomycin D in human plasma by liquid chromatography-mass spectrometry
    Veal, GJ
    Errington, J
    Sludden, J
    Griffin, MJ
    Price, L
    Parry, A
    Hale, J
    Pearson, ADJ
    Boddy, AV
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 795 (02): : 237 - 243
  • [38] Determination of the anti-cancer drug actinomycin D in human plasma by liquid chromatography-mass spectrometry
    Errington, J
    Veal, GJ
    Sludden, J
    Griffin, MJ
    Price, L
    Parry, A
    Hale, J
    Pearson, ADJ
    Boddy, AV
    BRITISH JOURNAL OF CANCER, 2003, 88 : S41 - S41
  • [39] An automated high throughput liquid chromatography-mass spectrometry process to assess the metabolic stability of drug candidates
    Drexler, Dieter M.
    Belcastro, James V.
    Dickinson, Kenneth E.
    Edinger, Kurt J.
    Hnatyshyn, Serhiy Y.
    Josephs, Jonathan L.
    Langish, Robert A.
    McNaney, Colleen A.
    Santone, Kenneth S.
    Shipkova, Petia A.
    Tymiak, Adrienne A.
    Zvyaga, Tatyana A.
    Sanders, Mark
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2007, 5 (02) : 247 - 264
  • [40] Integrating the lactulose-mannitol test for intestinal permeability with untargeted metabolomics for drug monitoring through dual liquid chromatography-mass spectrometry
    Hildebrand, Felina
    Cukaci, Cemre
    Schoeny, Harald
    Baumgartinger, Christoph
    Stelzer, Bruno
    Spedicato, Matteo
    Frey, Tobias
    Catani, Martina
    Schmetterer, Klaus
    Frey, Richard
    Koellensperger, Gunda
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2025,